[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2002320537A1 - Diaminediols for the treatment of alzheimer's disease - Google Patents

Diaminediols for the treatment of alzheimer's disease

Info

Publication number
AU2002320537A1
AU2002320537A1 AU2002320537A AU2002320537A AU2002320537A1 AU 2002320537 A1 AU2002320537 A1 AU 2002320537A1 AU 2002320537 A AU2002320537 A AU 2002320537A AU 2002320537 A AU2002320537 A AU 2002320537A AU 2002320537 A1 AU2002320537 A1 AU 2002320537A1
Authority
AU
Australia
Prior art keywords
diaminediols
alzheimer
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002320537A
Inventor
Robert Alan Chrusciel
Heinrich Josef Schostarez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Elan Pharmaceuticals LLC
Original Assignee
Pharmacia and Upjohn Co
Elan Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Elan Pharmaceuticals LLC filed Critical Pharmacia and Upjohn Co
Publication of AU2002320537A1 publication Critical patent/AU2002320537A1/en
Abandoned legal-status Critical Current

Links

AU2002320537A 2001-07-10 2002-07-10 Diaminediols for the treatment of alzheimer's disease Abandoned AU2002320537A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/304,305 2001-07-10
US60/334,480 2001-11-30

Publications (1)

Publication Number Publication Date
AU2002320537A1 true AU2002320537A1 (en) 2003-01-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP1392287B8 (en) Use of substituted azetidinone derivatives in the treatment of Alzheimer's disease
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2001233299A1 (en) Methods for treating alzheimer's disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
EE200200716A (en) Compounds for the Treatment of Alzheimer's Disease
AU2002306848A1 (en) Methods of treating alzheimer's disease with piperidin derivates
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2003303141A1 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
AU2003284898A1 (en) Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer's disease
EP1181550A4 (en) Methods for the identification of compounds for the treatment of alzheimer's disease
AU2002312667A1 (en) Individualization of therapy with alzheimer's disease agents
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
AU2002320537A1 (en) Diaminediols for the treatment of alzheimer's disease
AU2002316622A1 (en) Aminediols for the treatment of alzheimer's disease
AU2003286530A1 (en) Substituted peptides useful in the treatment of alzheimer's disease
AU2002350043A1 (en) Hydroxy substituted amides for the treatment of alzheimer's disease
AU2002318289A1 (en) Statine derivatives for the treatment of alzheimer's disease
AU2002303988A1 (en) Methods of treating alzheimer's disease
AUPR446101A0 (en) Treatment of alzheimer's disease (ad)